You are here


Universal Donor Immune Cells

An approach developed at the Weizmann Institute could make a cancer therapy cheaper and more effective

Genes that delay cell division exhibit reduced levels of expression (left) after exposure to a second, delayed pulse of growth factor. Those in cells receiving a single pulse (right box) maintained high expression levels

A gene that keeps cell division in check may hold clues to chemotherapy resistance. 

(l-r) Prof. Varda Rotter, Dr. Eldad Tzahor, Dr. Ariel Rinon, Alina Molchadsky and Dr. Rachel Sarig. Migration regulation

A gene that protects us from cancer is also involved in the timing of a crucial stage of embryonic development.

Eight Hours of Resistance

Why do cancer cells easily give in to the temptation to divide?

Prof. Roy Bar-Ziv and Dr. Lior Nissim. Identifying cancer

A new genetic sensor kills only the malignant cancer cells in a test tube.

(l-r) Liat Shachnai, Natalie Yivgi-Ohana, Prof. Atan Gross, Maria Maryanovich and Dr. Yehudit Zaltsman-Amir
A newly-discovered character in the cell suicide drama may be a promising target for anti-cancer drugs
Prof. Meir Wilchek
In the late 1980s, Prof. Meir Wilchek  developed an immune cancer therapy that employs "T bodies" – white...
Prof. Emeritus Nechama Haran-Ghera
Haran-Ghera’s research provided the scientific basis for clinical trials of erythropoietin in multiple myeloma and for testing the...
(l-r) Prof. Yosef Yarden and Dr. Yaron Mosesson. In the bubble

Cells missing a recycling mechanism get trapped in a cancer-causing cycle

New Protein Partnership

Weizmann Institute Scientists Discover A New Protein Partnership That Leads to Pediatric Tumor Regression